搜索结果


   GRIN2A

靶点ID:TCMBANKGE005653


靶点别名:EPND; FESD; GluN2A; LKS; NMDAR2A; NR2A


靶点描述:glutamate ionotropic receptor NMDA type subunit 2A


染色体:16


染色体位置:16p13.2


靶点类型:protein-coding


HERB_ID:-


HGNC_Link:4585


OMIM_Link:138253


Ensembl_Link:ENSG00000183454


   靶点对应的植物
ID 拉丁名 药名 药用植物名 功能与主治 来源 药用部位 使用民族

   靶点对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN000094 choline Choline chloride; choline hydroxide C5H14NO+ 104.17 g/mol C[N+](C)(C)CCO
TCMBANKIN011656 toddaline chelerythrine; toddaline C21H18NO4+ 348.4 g/mol C[N+]1=C2C(=C3C=CC(=C(C3=C1)OC)OC)C=CC4=CC5=C(C=C42)OCO5
TCMBANKIN016901 N-methyl-2-β-Hydroxypropyl piperidine C21H27NO2 CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3
TCMBANKIN026559 benzenemethanol Aromatic primary alcohol; 3983-EP2298734A2; D05OIS; Benzyl alcohol, polymer-bound, 70-90 mesh, extent of labeling: 2.0-3.0 mmol loading, 1 % cross-linked; Benzyl alcohol, USP, 98.0-100.5%; NSC 406252-d5; Benzyl alcohol, Vetec(TM) reagent grade, 98%; 3983-EP2308873A1; Alcool benzilico [DCIT]; 3983-EP2311842A2; 3983-EP2292612A2; Benzyl alcohol [USAN:INN:JAN]; 3983-EP2305696A2; 3983-EP2275401A1; J-000153; WVDDGKGOMKODPV-UHFFFAOYSA-N; 3983-EP2277568A2; 3983-EP2308854A1; benzylic alcohol; TR-033774; EINECS 202-859-9; 3983-EP2272841A1; PhCH2OH; Jsp000133; Benzyl alcohol, SAJ first grade, >=98.5%; 3983-EP2298744A2; Benzyl alcohol, polymer-bound, 100-200 mesh, extent of labeling: 1.0-2.0 mmol/g loading, 1 % cross-linked with divinylbenzene; Benzyl alcohol, polymer-bound, 70-90 mesh, extent of labeling: 0.5-1.0 mmol/g loading, 1 % cross-linked with divinylbenzene; Benzoyl alcohol; CTK0H6356; 3983-EP2280010A2; 3983-EP2270011A1; Benzyl alcohol, Pharmaceutical Secondary Standard; Certified Reference Material; Benzyl alcohol, polymer-bound; NSC8044; PENTADEOTEROBENZYL ALCOHOL; Benzylalkohol; 3983-EP2292614A1; Tox21_111172; 3983-EP2308858A1; benzylalcohol; STL163453; Benzyl alcohol, puriss. p.a., ACS reagent, >=99.0% (GC); Pharmakon1600-01502555; Polystyrene cross-linked with divinylbenzene, hydroxymethylated; I01-4406; Benzyl alcohol, analytical standard; DTXSID5020152; AS04466; ZB015017; (Hydroxymethyl)benzene; Benzyl alcohol, anhydrous, 99.8%; 3983-EP2270004A1; 3983-EP2287155A1; Caswell No. 081F; 3983-EP2305808A1; Sunmorl BK 20; EC 202-859-9; Benzal alcohol; 3983-EP2275411A2; RTR-033774; benzene-methanol; 3983-EP2275102A1; 3983-EP2301931A1; 2-PHENYL-D5-ETHANOL; 3983-EP2277569A2; 3983-EP2277570A2; KB-200532; 3983-EP2308846A2; 3983-EP2316831A1; Alcool benzilico; 3983-EP2295406A1; (Hydroxymethyl)polystyrene, 200-500 mesh, extent of labeling: ~1.1 mmol/g loading; 3983-EP2305640A2; CHEMBL720; 3983-EP2308845A2; 3983-EP2280008A2; Benzyl alcohol, United States Pharmacopeia (USP) Reference Standard; TOLUENE,ALPHA-HYDROXY; 3983-EP2295411A1; 3983-EP2292615A1; alcoholum benzylicum; BC222892; phenylmethanol; C6H5CH2OH; Phenyl-Methanol; MFCD00004599; (Hydroxymethyl)polystyrene, 200-400 mesh, extent of labeling: ~1.7 mmol/g loading; A800221; DTXSID40470349; NCGC00091865-01; InChI=1/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H; KSC176G5N; 3983-EP2280001A1; 3983-EP2287160A1; 3983-EP2289888A2; Itch-X; 3983-EP2311817A1; BENZYL ALCOHOL, U.S.P./N.F.; D00077; Benzyl alcohol, puriss., meets analytical specification of Ph.??Eur., BP, NF, 99-100.5% (GC); enzylalcohol; AKOS000119907; 2-(2,3,4,5,6-pentadeuteriophenyl)ethanol; 3983-EP2277867A2; Benzyl alcohol, >=99%, FCC, FG; Bentanol; NSC 8044; 3983-EP2380568A1; BENZYL ALCOHOL, ACS; 3983-EP2295426A1; 3983-EP2316836A1; Benzencarbinol; Phenylcarbinolum; hydroxy(phenyl)methyl; Methanol, phenyl-; Benzyl Alcohole; 3983-EP2311823A1; Benzyl alcohol (natural); Bn-OH; Benzalalcohol; Phenyl Methanol; 3983-EP2275414A1; SBB058558; 3983-EP2270505A1; C03485; 2-Phenyl-d5-ethanol, 98 atom % D, 98% (CP); a-Hydroxytoluene; 3983-EP2372017A1; EPA Pesticide Chemical Code 009502; 3983-EP2311829A1; Alcool benzylique; Benzyl alcohol, ACS reagent, >=99.0%; Alcoolbenzylique; 3983-EP2298783A1; 3983-EP2308875A1; 3983-EP2298768A1; Tox21_300044; 3983-EP2289887A2; 3983-EP2287166A2; 3983-EP2280003A2; 3983-EP2311831A1; Benzyl alcohol, LR, >=99%; 3983-EP2311806A2; I765; DSSTox_RID_75404; Benzenecarbinol; DSSTox_GSID_20152; LS41488; 3983-EP2272813A2; NCGC00254154-01; 2-[(2,3,4,5,6-(2)H?)PHENYL]ETHANOL; 3983-EP2295413A1; 3983-EP2308857A1; Phenylethyl Alcohol-d5; 3983-EP2277879A1; 3983-EP2311837A1; 3983-EP2314585A1; TB 13G; OBZ; 3983-EP2374454A1; BB_SC-7027; FT-0622812; C00556; Ulesfia; 3983-EP2305636A1; 3983-EP2305695A2; 3983-EP2277876A1; AK146334; BDBM16418; 3983-EP2314584A1; FT-0673679; CHEBI:17987; MFCD03792087; ACM35845637; Benzyl alcohol Natural; 3983-EP2305698A2; Benzyl alcohol, p.a., ACS reagent, 99.0%; Phenethyl Alcohol-d5; 3983-EP2295437A1; 3983-EP2298750A1; 4-06-00-02222 (Beilstein Handbook Reference); BIDD:ER0248; (Hydroxymethyl)polystyrene; SCHEMBL147; HMS3264B16; 3983-EP2308870A2; Polystyrene crosslinked with divinylbenzene, hydroxymethylated; AJ-24171; 3983-EP2305697A2; Nat. Benzyl Alcohol; CAS-100-51-6; 3983-EP2298755A1; 2-Phenethanol-d5; 3983-EP2270005A1; 3983-EP2374790A1; Benzyl alcohol, ReagentPlus(R), >=99%; 3983-EP2316834A1; 3983-EP2314575A1; 3983-EP2308833A2; 3983-EP2308812A2; Aromatic alcohol; 3983-EP2298743A1; 3983-EP2305651A1; Phenylmethyl alcohol; UNII-LKG8494WBH; alpha-hydroxytoluene; NCGC00259996-01; 3983-EP2295427A1; FEMA No. 2137; Benzeneethanol-d5; 3983-EP2316829A1; 3983-EP2316470A2; 3983-EP2292227A2; 100-51-6; 1336-27-2; StratoSpheres™ PL-HMS (Hydroxymethylstyrene) resin; MolPort-001-783-216; hydroxymethylbenzene; Benzylicum; 3983-EP2277565A2; NCGC00091865-02; Hydroxytoluene; a-Toluenol; 3983-EP2298775A1; Benzalcohol; Euxyl K 100; BnOH; BRN 0878307; 3983-EP2292596A2; Hydroxymethyl polystyrene; HY-B0892; Benzyl alcohol, polymer-bound, 100-200 mesh, extent of labeling: 0.5-1.0 mmol/g loading, 1 % cross-linked; CCG-213843; 3983-EP2289892A1; 3983-EP2274983A1; DSSTox_CID_152; Benzyl alcohol, natural, >=98%, FG; B2378; PINAPUR™ 9 BA-R; Benzyl alcohol, tested according to Ph.Eur.; 3983-EP2280005A1; SC-47293; 3983-EP2298731A1; benzyl alcohol; 3983-EP2272825A2; Benzyl alcohol (JP15/NF); .alpha.-Toluenol; s4600; 3983-EP2272822A1; 3983-EP2277566A2; 3983-EP2281823A2; Benzyl alcohol, PharmaGrade, USP/NF, Ph Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.; aplha-Hydroxytoluene; 3983-EP2279750A1; F0001-0019; 3983-EP2284160A1; Benzyl alkohol; NCGC00091865-03; Bentalol; 3983-EP2308867A2; 3983-EP2308861A1; benzenmethanol; 3983-EP2295550A2; Benzyl alcohol, AR, >=99.5%; 3983-EP2295412A1; BBL011938; HSDB 46; 3983-EP2275425A1; 3983-EP2308872A1; Alcool benzylique [INN-French]; 3983-EP2374783A1; CCRIS 2081; AI3-01680; Phenolcarbinol; 3983-EP2289884A1; Benzyl alcohol, SAJ special grade, >=99.0%; LKG8494WBH; 3983-EP2295402A2; ZINC895302; 3983-EP2298772A1; LS-307; Benzyl alcohol (JP17/NF/INN); DB06770; 3983-EP2374792A1; Benzyl alcohol, polymer-bound, 70-90 mesh, extent of labeling: 1.0-1.5 mmol/g loading, 1 % cross-linked; 3983-EP2272516A2; Alcoholum benzylicum [INN-Latin]; phenylcarbinol; 3983-EP2308844A2; phenylmethan-1-ol; 3983-EP2277848A1; Methanol benzene; 3983-EP2308877A1; Benzyl alcohol, certified reference material, TraceCERT(R); 3983-EP2289894A2; (2-Hydroxyethyl)benzene-d5; 2-Phenyl-1-ethanol-d5; SR-01000872610; Benzyl alcohol, 99% 250g; 2-Phenylethanol-d5; AC1L18SY; Benzene Carbinol; 3983-EP2287165A2; StratoSpheres(TM) PL-HMS (Hydroxymethylstyrene) resin, 50-100 mesh, extent of labeling: 2.0 mmol loading, 1 % cross-linked; 66072-40-0; 3983-EP2301936A1; Alcohol bencilico; 3983-EP2311834A1; 3983-EP2284149A1; Benzyl alcohol polymer-bound; MCULE-6011707909; NCI-C06111; Benzyl alcohol on polystyrene, 3.5 mmol/g; 35845-63-7; alpha-Toluenol; RP18893; 3983-EP2311815A1; NSC-760098; 3983-EP2292280A1; ST24048908; Alcohol bencilico [INN-Spanish]; ACMC-1BQPG; 3983-EP2301918A1; 3983-EP2311824A1; 3983-EP2269992A1; 3983-EP2277567A1; BENZYL-ALCOHOL; 3983-EP2316835A1; 3983-EP2272817A1; 3983-EP2292611A1; Benzyl alcohol, European Pharmacopoeia (EP) Reference Standard; 3762963D-6C2A-4BFF-AD94-3180E51BCA68; ST51028320; 3983-EP2305673A1; NSC-8044; 3983-EP2292620A2; Ulesfia (TN); AC1Q7C20; NSC760098; Benzyl Alcohol Reagent ACS Grade; bmse000407; 3983-EP2308839A1; E1519; SR-01000872610-3; Benzyl alcohol [INN:JAN:NF]; NCGC00091865-04; AB01563201_01; 3983-EP2280012A2; Z955123784; 3983-EP2308828A2; 185532-71-2; .alpha.-Hydroxytoluene; WLN: Q1R; 3983-EP2305676A1; 3983-EP2311816A1; 3983-EP2305243A1; 3983-EP2298735A1; Tox21_202447 C7H8O 108.14 CO.C1=CC=CC=C1
TCMBANKIN028288 morphine (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol; 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol; RMS; Hard stuff; Morpho; Cube juice; 47106-99-0; EINECS 200-320-2; 64-31-3 (SULFATE); (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol; (-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol; Morphin; Nepenthe; Roxanol; (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL; CCRIS 5762; AIDS-001987; Moscontin; Statex SR; Unkie; Morphia; Morphina [Italian]; M-Eslon; Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-, (5alpha,6alpha)-; Morphinum; Ms Emma; 4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol; (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol; Dolcontin; 9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4a,5,7a,8-tetrahydro-12-methyl-; Morphinism; Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5..alpha.,6.alpha.)-; MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE; 57-27-2 (FREE BASE ); (-)-Morphine; Dulcontin; 8053-16-5; Meconium; (-)Morphine sulfate; Ospalivina; NSC11441(SULFATE); Morphium; Morphin [German]; l-Morphine; 9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4alpha,5,7alpha,8-tetrahydro-12-methyl-; Dreamer; HSDB 2134; Hocus; 85201-37-2; AIDS001987; 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol; DEA No. 9300; Duromorph; Morfina [Italian]; Morphina; Morphinan-3,6-alpha-diol, 7,8-didehydro-4,5-alpha-epoxy-17-methyl-; MOI; CHEBI:17303 C17H19NO3 285.34 CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O
TCMBANKIN057923 glycin Tocris-0219; G5417_SIGMA; WLN: Z1VQ; LS-218; 56-40-6; Glycosthene; G7126_SIGMA; Hgly; Glycine-UL-14C hydrochloride; EINECS 200-272-2; Padil; Polyglycine II; AB-131/40217813; Acido aminoacetico [INN-Spanish]; Glycine [INN]; G7403_SIGMA; CCRIS 5915; GLY (IUPAC abbrev); W328707_ALDRICH; Glycine-2-3H; G3649_SIGMA; InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5; Glycine iron sulphate (1:1); NSC 25936; P8791_SIGMA; Leimzucker; Gyn-Hydralin; D00011; Aminoessigsaeure; 50046_FLUKA; Acidum aminoaceticum [INN-Latin]; Aminoethanoic acid; aminoacetic acid; AI3-04085; 33242-26-1; H2N-CH2-COOH; C00037; G8898_SIGMA; Glyzin; G0398_SIGMA; Amitone; Hampshire glycine; Glycocoll; G5523_SIGMA; Acide aminoacetique [INN-French]; Glycine-carboxy-14C hydrochloride; Glicina [INN-Spanish]; Glycinum [INN-Latin]; Glykokoll; ST5213923; 15527_RIEDEL; 7490-95-1; NChemBio.2007.13-comp1; Glycine, non-medical; BPBio1_001222; Biomol-NT_000195; 57678-19-0; Glycolixir; 63183-41-5; 87867-94-5; HSDB 495; AIDS071643; FEMA No. 3287; CHEBI:15428; 33226_RIEDEL; Sucre de gelatine; 17829-66-2; 410225_SIAL; NCGC00024503-01; 2-Aminoacetic acid; Aminoazijnzuur; NSC25936; Glycine (JP15/USP); polyglycine; 52955-63-2; carbonocyanidic acid; 32817-15-5; 2-aminoethanoic acid; Aciport; L-Glycine; Glicoamin; 25718-94-9; Acetic acid, amino-; G8790_SIGMA; AIDS-071643; NCGC00024503-02; Glycine, homopolymer (VAN); glycine;CHEMBL451140; N'-[N-(2a,3b-Dihydroxy-12-oleanen-28-oyl)-L-alanyl]-glycine; 2-[[(2S)-2-[[(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carbonyl]amino]propanoyl]amino]acetic acid;GLY C2H5NO2 75.07 g/mol C(C(=O)O)N
TCMBANKIN057929 serine (s)-serine;H-Ser; Serinum [Latin]; 56-45-1; SCHEMBL1775; L-Serine, Vetec(TM) reagent grade, >=99%; bmse000867; (2S)-2-amino-3-hydroxypropanoic acid; Serine (L-Serine); EC 200-274-3; 6898-95-9; CS-W020136; L-Serine, homopolymer; CHEBI:17115; H-Ser-OH; S0035; L-Serine, PharmaGrade, Ajinomoto, EP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture; 2-Amino-3-hydroxypropanoic acid-, (S)-; b-Hydroxy-L-alanine; Propanoic acid, 2-amino-3-hydroxy-, (S); L-2-Amino-3-hydroxypropanoic Acid; BRN 1721404; EBD2198140; BC676679; Serinum; Serine (VAN); L-Serine;; NSC760115; (S)-(-)-Serine; AJ-24136; L-3-Hydroxy-2-aminopropionic acid; UNII-00PAR1C66F component MTCFGRXMJLQNBG-REOHCLBHSA-N; EINECS 200-274-3; TC-066532; L-Serine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%; ZINC895034; TL806218; (L)-SERINE; 61748-67-2; L-Serine, Vetec(TM), 98.5%; L-Serine, PharmaGrade, Ajinomoto, EP, USP, JP, Manufactured under appropriate controls for use in pharma or biopharmaceutical production, suitable for cell culture; NCGC00015952-01; Serine (USP); beta-Hydroxyalanine; L-Serine, BioUltra, >=99.5% (NT); Racemic serine; L-Serin; (S)-beta-Amino-3-hydroxypropionate; L-(-)-Serine; NSC 118365; Pharmakon1600-01301010; BR-73019; AK-73019; AmbotzHAA1129; (-)-Serine; (S)-alpha-Amino-beta-hydroxypropionic acid; (2S)-2-amino-3-hydroxy-propanoic acid; CTK1G9788; GTPL726; 452VLY9402; DB00133; 88848-EP2289892A1; MFCD00064224; l-2-Amino-3-hydroxy-propanoic acid; (S)-(+)-2-Amino-3-hydroxypropionic acid; Tocris-0226; (2S)-2-AMINO-2-CARBOXY-1-HYDROXYETHYL; AKOS015854115; 154605-73-9; bmse000048; alpha-Amino-beta-hydroxypropionic acid; bmse000809; MolPort-003-939-270; ser; LS-144975; 88848-EP2305825A1; (S)-a-Amino-b-hydroxypropionic acid; serine; RP09655; DB-029983; RP18847; AC1L1LHF; L-Serine (JP17); L-Serine, Pharmaceutical Secondary Standard; Certified Reference Material; AC-1190; .beta.-Hydroxyalanine; KSC269O8R; KB-53386; BDBM50357212; RTC-066532; NCGC00024507-02; NSC-760115; Lopac-S-4250; D00016; Serina; Propanoic acid, 2-amino-3-hydroxy-, (S)-; NCGC00024507-01; (S)-2-Amino-3-hydroxypropanoic acid; Polyserine; L-Serine, United States Pharmacopeia (USP) Reference Standard; MCULE-5604658333; AM20100375; (S)-Serine; SC-09827; Tocris-0227; L-2-Amino-3-hydroxypropionic acid; bmse000885; AB1002443; UNII-452VLY9402; beta-Hydroxy-L-alanine; 064S224; Serina [Spanish]; L-Serine, Cell Culture Reagent; HSDB 680; Serine, L-; FT-0693445; Serine, European Pharmacopoeia (EP) Reference Standard; L-serine; 3h-l-serine; C00065; (S)-alpha-Amino-beta-hydroxypropionate; L-Serine, certified reference material, TraceCERT(R); Serine [USAN:INN]; 25821-52-7; .alpha.-Amino-.beta.-hydroxypropionic acid-, (S)-; 2-Amino-3-hydroxypropanoic acid, (S)-; F1905-7047; (S)-2-amino-3-hydroxy-Propanoate; (S)-beta-Amino-3-hydroxypropionic acid; L-Serine, ReagentPlus(R), >=99% (HPLC); (S)-2-Amino-3-hydroxypropionic acid; L-Serine, >=99.0% (NT); SR-01000597708; (S)-2-Amino-3-hydroxypropanoate; AN-24441; ST2408299; BP-13282; (S)-2-amino-3-hydroxy-Propanoic acid; CHEMBL11298; 3-hydroxy-L-Alanine; MTCFGRXMJLQNBG-REOHCLBHSA-N; L-Serine, tested according to Ph.Eur.; D0T6GM; PubChem10994; VC30786; Epitope ID:150900; L-3-Hydroxy-2-aminopropionate; L-3-Hydroxy-alanine; M-6047; FT-0627627; Z1270387256; SR-01000597708-1; 3AB40D3A-043A-488F-8361-D1BF309F842C; 4-04-00-03118 (Beilstein Handbook Reference); AB0008559; (S)-a-Amino-b-hydroxypropionate; SER (IUPAC abbrev); L-Alanine, 3-hydroxy-; L-ser; ACT08366; (S)-b-Amino-3-hydroxypropionate; (S)-b-Amino-3-hydroxypropionic acid; 2-Amino-3-hydroxypropionic acid; Poly-L-serine; ANW-32514; rac-serine;(S)-2-Amino-3-hydroxypropionic acid; 2-Amino-3-hydroxypropanoic acid; Serinum [Latin]; S4311_SIGMA; NCGC00024507-02; NSC 118365; Lopac-S-4250; D00016; (2S)-2-amino-3-hydroxypropanoic acid; (-)-Serine; (2S)-2-amino-3-hydroxy-propionic acid; Propanoic acid, 2-amino-3-hydroxy-, (S)-; (S)-alpha-Amino-beta-hydroxypropionic acid; 6898-95-9; (2S)-2-amino-3-hydroxy-propanoic acid; NCGC00024507-01; L-Serine, homopolymer; CHEBI:17115; (S)-2-Amino-3-hydroxypropanoic acid; Polyserine; Propanoic acid, 2-amino-3-hydroxy-, (S); L-3-Hydroxy-alanine; Tocris-0226; (S)-Serine; Tocris-0227; BRN 1721404; L-2-Amino-3-hydroxypropionic acid; beta-Hydroxy-L-alanine; Serina [Spanish]; Serine (VAN); 84959_FLUKA; alpha-Amino-beta-hydroxypropionic acid; HSDB 680; Serine, L-; C00065; 4-04-00-03118 (Beilstein Handbook Reference); L-3-Hydroxy-2-aminopropionic acid; EINECS 200-274-3; L-Serine (JAN); SER (IUPAC abbrev); Serine [USAN:INN]; 25821-52-7; 78682_FLUKA; 2-Amino-3-hydroxypropanoic acid, (S)-; L-Alanine, 3-hydroxy-; S1315_SIGMA; NCGC00015952-01; Serine (USP); Poly-L-serine; beta-Hydroxyalanine; S4500_SIGMA;L-Serin C3H7NO3 105.09 g/mol C(C(C(=O)O)N)O
TCMBANKIN057989 2-amino-4-mercaptobutanoic acid Demethylation Lindera base C4H9NO2S 135.18 C(CS)C(C(=O)O)N
TCMBANKIN058277 2-hydroxybenzoic acid O-hydroxybenzoic acid; 3- coffee acid; Thick-stemmed black base C7H6O3 or HOC6H4COOH 138.12 g/mol C1=CC=C(C(=C1)C(=O)O)O
TCMBANKIN058301 Hydroxy benzyl alcohol C7H8O2 124.14 g/mol C1=CC=C(C=C1)C(O)O
TCMBANKIN058355 Aromatic alcohol NSC 8044; Aromatic primary alcohol; HSDB 46; alpha-hydroxytoluene; benzyl alcohol; AIDS009274; AIDS-009274; CCRIS 2081; Alcohol bencilico [INN-Spanish]; (Hydroxymethyl)benzene; W213705_ALDRICH; AI3-01680; FEMA No. 2137; 4-06-00-02222 (Beilstein Handbook Reference); Hydroxytoluene; benzenemethanol; Benzyl alcohol (JP15/NF/INN); 24122_RIEDEL; 442481_SUPELCO; Phenolcarbinol; NCGC00091865-01; InChI=1/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H; Euxyl K 100; .alpha.-Toluenol; BENZYL-ALCOHOL; Caswell No. 081F; BRN 0878307; Benzoyl alcohol; C00556; Benzal alcohol; 402834_SIAL; 100-51-6; 1336-27-2; LS-307; Phenylcarbinolum; Methanol, phenyl-; 305197_ALDRICH; NSC8044; c0278; Benzyl alcohol (natural); 185532-71-2; Benzenecarbinol; hydroxymethylbenzene; C03485; Alcool benzilico [DCIT]; NCI-C06111; TOLUENE,ALPHA-HYDROXY; 108006_ALDRICH; Benzylalkohol; alpha-Toluenol; 13160_FLUKA; Benzyl alcohol [USAN:INN:JAN]; EINECS 202-859-9; CHEBI:17987; Alcoholum benzylicum [INN-Latin]; EPA Pesticide Chemical Code 009502; phenylcarbinol; 34460_RIEDEL; .alpha.-Hydroxytoluene; Benzylicum; D00077; W213713_ALDRICH; alcoholum benzylicum; benzylalcohol; phenylmethanol; Phenylmethyl alcohol; benzylic alcohol; Alcool benzylique; Alcool benzylique [INN-French];benzyl alcohol;WLN: Q1R C7H8O 108.14 g/mol C1=CC=C(C=C1)CO
TCMBANKIN058381 4-hydroxy-2-quinolinecarboxylic acid kynurenic acid; KYNA C10H7NO3 189.17 g/mol C1=CC=C2C(=C1)C(=O)C=C(N2)C(=O)O
TCMBANKIN060756 isorhynchophylline C22H28N2O4 384.5 g/mol CCC1CN2CCC3(C2CC1C(=COC)C(=O)OC)C4=CC=CC=C4NC3=O
TCMBANKIN061198 1- Pentanol C5H12O 88.15 g/mol CCCCCO
TCMBANKIN061675 berberime berberine ; isoquinoline alkaloid; berberine C20H18NO4+ 336.4 g/mol COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC

   靶点对应的疾病
疾病ID 疾病名 MeSH名 HPO名 UMLS名 疾病类型
TCMBANKDI000002 Pathological Conditions, Signs and Symptoms; Nervous System Diseases Abnormality of the nervous system Sign or Symptom phenotype
TCMBANKDI000023 Skin and Connective Tissue Diseases; Immune System Diseases Abnormality of the immune system Disease or Syndrome disease
TCMBANKDI000054 Nervous System Diseases; Mental Disorders Abnormality of the nervous system Disease or Syndrome disease
TCMBANKDI000066 Mental Disorders Abnormality of the nervous system Mental or Behavioral Dysfunction disease
TCMBANKDI000935 Mental Disorders - Mental or Behavioral Dysfunction disease
TCMBANKDI001795 Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases - Injury or Poisoning disease
TCMBANKDI003580 Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms Abnormality of the nervous system Mental or Behavioral Dysfunction disease
TCMBANKDI004145 Mental Disorders Abnormality of the nervous system Mental or Behavioral Dysfunction group
TCMBANKDI006187 Pathological Conditions, Signs and Symptoms; Nervous System Diseases - Sign or Symptom phenotype
TCMBANKDI007332 Behavior and Behavior Mechanisms - Mental or Behavioral Dysfunction disease
TCMBANKDI007343 Pathological Conditions, Signs and Symptoms; Nervous System Diseases - Finding phenotype
TCMBANKDI007964 Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms Abnormality of the nervous system Mental or Behavioral Dysfunction group
TCMBANKDI008275 Pathological Conditions, Signs and Symptoms; Nervous System Diseases Abnormality of the nervous system Disease or Syndrome disease
TCMBANKDI009231 Pathological Conditions, Signs and Symptoms; Infections Abnormality of the immune system Disease or Syndrome disease
TCMBANKDI009278 Mental Disorders - Mental or Behavioral Dysfunction group
TCMBANKDI009657 Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases Abnormality of the cardiovascular system Congenital Abnormality group
TCMBANKDI010675 Chemically-Induced Disorders; Mental Disorders - Mental or Behavioral Dysfunction disease
TCMBANKDI010896 Nervous System Diseases Abnormality of the nervous system Disease or Syndrome group
TCMBANKDI011397 Pathological Conditions, Signs and Symptoms; Nervous System Diseases - Disease or Syndrome phenotype
TCMBANKDI011814 - - Neoplastic Process phenotype
TCMBANKDI014716 Nervous System Diseases - Disease or Syndrome disease
TCMBANKDI015068 Infections; Immune System Diseases - Disease or Syndrome disease
TCMBANKDI015081 Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms Abnormality of the nervous system Mental or Behavioral Dysfunction disease
TCMBANKDI015256 Chemically-Induced Disorders; Mental Disorders - Mental or Behavioral Dysfunction phenotype
TCMBANKDI015485 Mental Disorders Abnormality of the nervous system Mental or Behavioral Dysfunction disease
TCMBANKDI017008 Pathological Conditions, Signs and Symptoms; Nervous System Diseases Abnormality of the nervous system Disease or Syndrome disease
TCMBANKDI017789 - Abnormality of the nervous system Disease or Syndrome disease
TCMBANKDI017839 - Abnormality of the nervous system Finding phenotype
TCMBANKDI017864 Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Musculoskeletal Diseases; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms - Disease or Syndrome disease
TCMBANKDI021622 Mental Disorders - Mental or Behavioral Dysfunction disease
TCMBANKDI023044 Mental Disorders - Mental or Behavioral Dysfunction group
TCMBANKDI023401 Chemically-Induced Disorders; Mental Disorders - Mental or Behavioral Dysfunction disease
TCMBANKDI023437 Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases - Disease or Syndrome disease
TCMBANKDI023464 Nervous System Diseases Abnormality of the nervous system Disease or Syndrome disease
TCMBANKDI023866 Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases Abnormality of the nervous system; Abnormality of head or neck; Abnormality of the skeletal system Congenital Abnormality disease
TCMBANKDI024174 - Abnormality of the nervous system Finding phenotype
TCMBANKDI024699 Pathological Conditions, Signs and Symptoms; Nervous System Diseases Abnormality of the nervous system Mental or Behavioral Dysfunction disease
TCMBANKDI026165 Nervous System Diseases - Disease or Syndrome disease
TCMBANKDI026352 Pathological Conditions, Signs and Symptoms; Nervous System Diseases - Mental or Behavioral Dysfunction group
TCMBANKDI028664 - - Finding phenotype
TCMBANKDI028945 Pathological Conditions, Signs and Symptoms; Nervous System Diseases Abnormality of the nervous system Disease or Syndrome disease
TCMBANKDI029054 Mental Disorders - Mental or Behavioral Dysfunction group
TCMBANKDI029981 - Abnormality of the voice Anatomical Abnormality disease
TCMBANKDI030306 Pathological Conditions, Signs and Symptoms; Nervous System Diseases - Disease or Syndrome disease
TCMBANKDI031570 - Abnormality of the nervous system Mental or Behavioral Dysfunction disease
TCMBANKDI032193 Behavior and Behavior Mechanisms Abnormality of the nervous system Mental or Behavioral Dysfunction phenotype